
Pharma Companies May Miss Crucial EU Drug Packaging Deadline
Many EU and U.S. pharma companies are unaware that if a no-deal Brexit is reached between the U.K. and the EU, they will need to meet a crucial EU export administration deadline by March 29, 2019, a regulatory expert has confirmed. Fiona Barry, associate editor, PharmSource, a GlobalData product, attending the recent Convention on Pharmaceutical Ingredients (CPhI)…
Report: Opioid Use Disorder Market Set to Grow to $4.8B by 2027
Sandoz Abandoning U.S. Development of Rixathon
Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimilar version of Roche’s Rituxan/MabThera (rituximab). Despite the fact that not seeking approval in the US is a lost opportunity in the short term, Sandoz’s strategy to prioritize other more profitable markets for Rixathon will benefit the company in…
Report: Six New Obesity Drugs Set to Launch by 2026
Amazon Appears Poised to Make Huge Strides in Healthcare
With a business model that facilitates easier connectivity between providers and patients, a powerful online platform and artificial intelligence (AI) interface, Alexa, Amazon is predicted to make huge strides in healthcare, says data and analytics company GlobalData. In 2016, the U.S. spent $3.3 trillion or $10,348 per person for healthcare. Even though healthcare spending in the U.S.…